Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-02

FDA Approved: ETRAVIRINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves the original application for etravirine from Bionpharma Inc., making a generic NNRTI available for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

ORIG AP for ETRAVIRINE (ETRAVIRINE)